CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 9, 2022 · earnings

CRSP earnings: a negative outcome, -10.0%

On May 9, 2022, CRISPR Therapeutics AG reached its earnings. The result was a negative outcome, and the stock moved -10.0% in the window around the event. It had already run -22.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$48.01
1d before
$43.23
Event day
$47.31
1d after
$52.23
5d after

Pre-catalyst setup

-22.1%
30-day run-up
6748%
30-day volatility
1.5×
volume spike